Strong Funding Leverage Fannin has demonstrated consistent access to substantial funding through SBIR grants and equity financing, indicating a robust financial foundation that supports ongoing research and development, making it an attractive partner for companies seeking funding support or collaborative ventures.

Expanding Portfolio With plans to develop 15-20 new portfolio companies over the next three to five years, Fannin offers significant partnership and investment opportunities in early-stage biotech ventures that are aligned with innovative health solutions.

Collaborative Research Focus Fannin’s active partnerships with top-tier medical institutions and its involvement in cutting-edge therapeutic development, such as targeted treatments for AMD and leukemia, create opportunities to connect with research teams and co-developing companies in these niches.

Growth in Life Sciences As an incubator and co-founder with a growing pipeline in the Texas Medical Center, Fannin’s strategic position provides access to emerging technologies and startups focused on therapeutics, diagnostics, and medical devices, ideal for businesses targeting early adoption or partnership.

Innovation Networks Fannin’s extensive network of industry experts, entrepreneurs, and academic institutions in Houston delivers excellent avenues for outreach and relationship-building in the biotech ecosystem, facilitating introductions to promising startups and key decision-makers.